To the Editor: We report on a patient with type 1 diabetes mellitus, diagnosed at 16 years of age, in whom widespread amyloid deposits developed many years later in transplanted human islets. The islets were administered through three intraportal infusions: two infusions were administered 4 months apart when the patient was 50 years of age, and one infusion was administered when he was 54 years of age.
No takes yet. Share an insight, caveat, or question.
Westermark et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: